Default object view. Click to create a custom template, Node ID: 169167, Object ID: 101429

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised c...

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Tags: Early Early , Locally advanced Locally advanced , Metastatic Metastatic

No relation

Yes

No relation

No

12/12/2016 3:21 pm

No